Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Rhabdomyolysis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report.

Bielen R, Verswijvel G, Van der Speeten K.

Case Rep Oncol. 2013 Jan;6(1):36-44. doi: 10.1159/000346471. Epub 2013 Jan 18.

2.

[Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis caused by recurrent inflammatory myofibroblastic sarcoma: a case report and review of the literature].

Mátrai Z, Péley G, Kovács T, Rényi VF, Szívós E, Szabó E, Vereczkey I, Török K, Köves I.

Orv Hetil. 2006 Jan 29;147(4):147-58. Review. Hungarian.

PMID:
16515023
3.

Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.

Piso P, Slowik P, Popp F, Dahlke MH, Glockzin G, Schlitt HJ.

Ann Surg Oncol. 2009 Aug;16(8):2188-94. doi: 10.1245/s10434-009-0478-5. Epub 2009 May 2.

PMID:
19408049
4.

Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.

Cashin PH, Graf W, Nygren P, Mahteme H.

Eur J Surg Oncol. 2012 Jun;38(6):509-15. doi: 10.1016/j.ejso.2012.03.001. Epub 2012 Apr 3.

PMID:
22475555
5.

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis secondary to urachal adenocarcinoma.

Krane LS, Kader AK, Levine EA.

J Surg Oncol. 2012 Mar;105(3):258-60. doi: 10.1002/jso.22081. Epub 2011 Aug 30.

PMID:
22271499
6.

Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan.

Mizumoto A, Canbay E, Hirano M, Takao N, Matsuda T, Ichinose M, Yonemura Y.

Gastroenterol Res Pract. 2012;2012:836425. doi: 10.1155/2012/836425. Epub 2012 Jun 18.

7.

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.

Yang XJ, Li Y, al-shammaa Hassan AH, Yang GL, Liu SY, Lu YL, Zhang JW, Yonemura Y.

Ann Surg Oncol. 2009 Feb;16(2):345-51. doi: 10.1245/s10434-008-0226-2. Epub 2008 Nov 19.

PMID:
19018599
8.

Clinical efficacy of cytoreductive surgery and hyperthermic chemotherapy in peritoneal carcinomatosis from gastric cancer.

Ströhlein MA, Bulian DR, Heiss MM.

Expert Rev Anticancer Ther. 2011 Oct;11(10):1505-8. doi: 10.1586/era.11.147.

PMID:
21999124
9.

Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.

Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O, Cotte E.

J Surg Oncol. 2012 Aug 1;106(2):197-203. doi: 10.1002/jso.23062. Epub 2012 Feb 13.

PMID:
22331814
10.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis.

Ellison LM, Man Y, Stojadinovic A, Xin H, Avital I.

Chin J Cancer Res. 2017 Feb;29(1):86-92. doi: 10.21147/j.issn.1000-9604.2017.01.10.

11.

Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.

Iversen LH, Rasmussen PC, Laurberg S.

Br J Surg. 2013 Jan;100(2):285-92. doi: 10.1002/bjs.8908. Epub 2012 Nov 2.

PMID:
23124619
12.

Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.

Detroz B, Laurent S, Honoré P, Blaffart F, Limet R, Meurisse M.

Acta Chir Belg. 2004 Aug;104(4):377-83. Review.

PMID:
15469146
13.
14.

Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer.

Ansaloni L, Agnoletti V, Amadori A, Catena F, Cavaliere D, Coccolini F, De Iaco P, Di Battista M, Framarini M, Gazzotti F, Ghermandi C, Kopf B, Saponara M, Tauceri F, Vallicelli C, Verdecchia GM, Pinna AD.

Int J Gynecol Cancer. 2012 Jun;22(5):778-85. doi: 10.1097/IGC.0b013e31824d836c.

PMID:
22572845
15.

The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.

Hompes D, D'Hoore A, Van Cutsem E, Fieuws S, Ceelen W, Peeters M, Van der Speeten K, Bertrand C, Legendre H, Kerger J.

Ann Surg Oncol. 2012 Jul;19(7):2186-94. doi: 10.1245/s10434-012-2264-z. Epub 2012 Mar 7.

PMID:
22395983
16.

Palliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: current clinical practice or misnomer?

Lambert LA, Harris A.

J Gastrointest Oncol. 2016 Feb;7(1):112-21. doi: 10.3978/j.issn.2078-6891.2015.132. Review.

17.

Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

Weber T, Roitman M, Link KH.

Clin Colorectal Cancer. 2012 Sep;11(3):167-76. doi: 10.1016/j.clcc.2012.01.001. Epub 2012 Mar 6. Review.

PMID:
22397952
18.

Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program.

Chua TC, Martin S, Saxena A, Liauw W, Yan TD, Zhao J, Lok I, Morris DL.

Ann Surg. 2010 Feb;251(2):323-9. doi: 10.1097/SLA.0b013e3181c9b53c.

PMID:
20040853
19.

8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.

Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H.

Ann Surg Oncol. 2008 Sep;15(9):2426-32. doi: 10.1245/s10434-008-9966-2. Epub 2008 Jun 3.

PMID:
18521686
20.

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.

Franko J, Ibrahim Z, Gusani NJ, Holtzman MP, Bartlett DL, Zeh HJ 3rd.

Cancer. 2010 Aug 15;116(16):3756-62. doi: 10.1002/cncr.25116.

Supplemental Content

Support Center